MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. (MIRA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mira · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MIRA Pharmaceuticals, Inc. (MIRA) measures how much investors pay for each dollar of the company's trailing earnings. MIRA's current PE ratio of N/A is calculated by dividing its stock price of $1.00 by its TTM earnings per share of -$0.23.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - General · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MIRA Pharmaceuticals, Inc.You MIRA | $42M | N/A | — | -$0.23 |
 AN2 Therapeutics, Inc. ANTX | $105M | N/A | — | -$1.16 |
 Apimeds Pharmaceuticals US, Inc APUS | $2M | N/A | — | -$0.55 |
 IGC Pharma, Inc. IGC | $30M | N/A | — | -$0.07 |
 Milestone Scientific Inc. MLSS | $34M | N/A | — | -$0.07 |
 Modular Medical, Inc. MODD | $10M | N/A | — | -$15.26 |
 Myomo, Inc. MYO | $49M | N/A | — | -$0.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.44 | — | |
2024-12-31 FY2024 | — | $-0.51 | — | |
2023-12-31 FY2023 | — | $-0.65 | — | |
2022-12-31 FY2022 | — | $-0.48 | — | |
2021-12-31 FY2021 | — | $-0.15 | — | |
2020-12-31 FY2020 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MIRA Pharmaceuticals, Inc. (MIRA) measures how much investors pay for each dollar of the company's trailing earnings. MIRA's current PE ratio of N/A is calculated by dividing its stock price of $1.00 by its TTM earnings per share of -$0.23.
Frequently asked questions
MIRA pe ratio · 6 questionsMIRA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.00 and TTM EPS of -$0.23. Data sourced from Financial Modeling Prep via MIRA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MIRA Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09